Search criteria | ||||
Budget IMPACT Analysis of a Reduced Maintenance Dose of Certolizumab Pegol in Patients with Axial Spondyloarthritis in the United Kingdom | ||||
Kiri S, Arteaga Duarte C, Lamotte M, Gerlier L | ||||
IQVIA HEOR Zaventem | ||||
ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 107821 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2020 | English | , clinical setting: Secondary care, Cost effectiveness | |
Cost-Effectiveness Analysis of Certolizumab Pegol Versus Secukinumab and Ixekizumab in Non-Radiographic Axial Spondyloarthritis in the U.S | ||||
Kiri S, Arteaga Duarte Ca, Lee E, Low R, Tsakeu E, Lamotte M, Gerlier L. | ||||
IQVIA HEOR Zaventem | ||||
AMCP Nexus 2020 Virtual October 19. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2020 | English | , clinical setting: Secondary care, Cost effectiveness | |
Reduction in the Utilization of Prednisone or Methotrexate in Canadian Claims Data Following Initiation of Etanercept in Pediatric Patients with Juvenile Idiopathic Arthritis | ||||
Majed M M Khraishi1, Brad Millson2, John Woolcott3, Lisa Marshall4 and Heather Jones4 | ||||
1Memorial University of Newfoundland, St John's, NF, Canada, 2IQVIA, Kanata, ON, Canada, 3Global Outcomes & Evidence, Pfizer, Collegeville, PA, 4Pfizer, Collegeville, PA | ||||
Annals of the Rheumatic Diseases 2018;77:494. |
||||
, Article | ||||
, Canada | ||||
Abstract: https://acrabstracts.org/abstract/reduction-in-the-utilization-of-prednisone-and-or-methotrexate-following-the-initiation-of-etanercept-in-pediatric-patients/ | ||||
Condition | Year | Language | Analysis type | |
, Pediatrics, Rheumatology | 2019 | English | , Longitudinal study, Retrospective database analysis | |
Real-world utilization of methotrexate or prednisone co-therapy with etanercept among Canadian patients with rheumatoid arthritis: a retrospective cohort study | ||||
Majed Khraishi, Jelena Ivanovic, Yvonne Zhang, Brad Millson, Marie-Josee Brabant, John Woolcott, Heather Jones & Cinzia Curiale | ||||
Journal of Current Medical Research and Opinion, Accepted author version posted online: 25 Jun 2019, Published online: 10 Jul 2019 |
||||
, Article | ||||
, Canada | ||||
Abstract: ?https://doi.org/10.1080/03007995.2019.1636543 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2019 | English | , Retrospective cohort analysis | |
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain. | ||||
Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W. | ||||
IQVIA, Real World Evidence, London N1 9JY, UK. Lilly Spain, Health Outcomes & RWE, Alcobendas 28108, Spain. Lilly Spain, Medical, Alcobendas 28108, Spain. Lilly, Global Patient Reported Outcomes and Real World Evidence (GPORWE) International, Windlesham, Surrey GU20 6PH, UK. | ||||
Clinicoecon Outcomes Res. 2019 Jun 6;11:395-403 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.dovepress.com/cost-effectiveness-analysis-of-baricitinib-versus-adalimumab-for-the-t-peer-reviewed-fulltext-article-CEOR | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2019 | English | , Retrospective cohort analysis | |
Biological Treatment Patterns with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up | ||||
Cañete JD1, Naranjo A2, Calvo J3, Ordás C4, Aragón B5, Nocea G5, Roset M6, Fernández-Nebro A7 | ||||
1 Servicio de Reumatología, Hospital Clínic e IDIBAPS, Barcelona, Spain 2 Departamento de Reumatología, Hospital Dr. Negrín, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain 3 Departamento de Reumatología, Hospital General Universitario de Valencia, Valencia, Spain 4 Departamento de Reumatología, Hospital de Cabueñes, Gijón, Spain 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, Spain 6 IQVIA, Barcelona, Spain 7 Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain | ||||
Reumatol Clin. 2019 Jan 28. pii: S1699-258X(18)30259-6 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30704919 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2019 | Spanish | , Population Based Study, Survey research | |
Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use | ||||
Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M | ||||
IQVIA | ||||
Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372 |
||||
, Article | ||||
, France, Greece, Italy, Portugal | ||||
Abstract: https://www.omicsonline.org/open-access/evaluation-of-the-effectiveness-of-risk-minimisation-measures-targeting-physicians-on-prescribing-practices-of-thiocolchicoside-co-2161-1165-1000372-108159.html | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Rheumatology, Risk Management & REMS | 2019 | English | , Survey research | |
Two-year adherence and costs for biologic therapy for rheumatoid arthritis | ||||
Stolshek BS, Wade S, Mutebi A, De AP, Wade RL, Yeaw J | ||||
Amgen, IQVIA | ||||
Am J Manag Care |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ajmc.com/journals/issue/2018/2018-vol24-sp8/twoyear-adherence-and-costs-for-biologic-therapy-for-rheumatoid-arthritis?p=1 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2018 | English | , Cost analysis, Retrospective cohort analysis | |
Assessing Treatment Tolerability for Rheumatoid Arthritis. Validation and Practical Applications of the ‘TOL-AR-18 Questionnaire | ||||
Corominas H, Espadaler L, Gómez A, Ros I, Urruticoechea A, Sarmiento M, Sanmartí R | ||||
Corominas H.: Rheumatology and Autoimmune diseases Division, Hospital Universitari de Sant Pau & Hospital Dos de Maig, Barcelona, Spain Sarmiento M: Real-World Evidence Solutions, IMS Health, Spain | ||||
Reumatología Clínica 2018; Sep 5. [Epub ahead of print] |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.reumatologiaclinica.org/en/assessing-treatment-tolerability-for-rheumatoid/avance-resumen/S1699258X18301232/ | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Rheumatology | 2018 | English | , Clinical setting: hospital, Observational study | |
Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients – Three-Year Results from the COMPANION Study in Rheumatology Patients | ||||
Bessette L1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3 | ||||
1 Department of Medicine, Laval University, Quebec City, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada; 3AbbVie Corporation, St. Laurent, Quebec, Canada | ||||
Canadian Rheumatology Association 2017 Scientific Meeting, February 8-11, Ottawa, Canada |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/abbvie-cra-2017.pdf | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2017 | English | , Database Study | |
Regional policies impact on biosimilar adoption for autoimmune diseases in Italy | ||||
Tucci C1, Rova A1, Mantuano M1, Tettamanti A1 | ||||
QuintilesIMS, Milan, Italy | ||||
ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Gastrointestinal disorders, Health policy, Rheumatology | 2017 | English | , Literature Review | |
Market share and switching dynamics between Etanercept and its biosimilar product in Sweden and Germany: a real-world preliminary analysis. | ||||
Alten R1, Neregård P2, Jones HE3, Meng T4, Curiale C5, Singh E6, Lucchese L7, Gossen N8, Bergman GJ9, Miglio C7 | ||||
1 Shlosspark-Klinik Teaching Hospital of the Charité, Berlin, Germany 2 Pfizer, Sollentuna, Sweden 3 Pfizer inc., Collegeville, PA, USA 4 Pfizer Pharma GmbH, Berlin, Germany 5 Pfizer, Rome, Italy 6 Pfizer Inc., Collegeville, PA, USA 7 QuintilesIMS, London, UK 8 QuintilesIMS, Frankfurt, Germany 9 QuintilesIMS, Solna, Sweden | ||||
ISPOR 20th Annual European Congress |
||||
, Germany, Nordic, Sweden | ||||
Abstract: https://www.ispor.org/Event/ProgramList/2017Glasgow?type=Poster&sess=II&acode=PSY | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Patient Registries & Real-World Study Methods, Rheumatology | 2017 | English | , Retrospective database analysis | |
Depression risk in patients with rheumatoid arthritis in the United Kingdom | ||||
Jacob L,Rockel T, Kostev K | ||||
Rheumatol Ther. 2017 Mar 20. doi: 10.1007/s40744-017-0058-2. [Epub ahead of print] |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Rheumatology | 2017 | English | ||
COMMONALITIES AND DIFFERENCES IN DATA COLLECTION ACROSS EUROPEAN SPONDYLOARTHRITIS REGISTRIES | ||||
M. L. Hetland* 1, M. Østergaard1, J. Askling2, C. Gabay3, D. Nordstrom4, O. FitzGerald5, M. Hernández Miguel6, M. Santos7 , Z. Rotar8, H. Mann9, F. Iannone10, M. J. Nissen3, E. Hauge1, J. Gomez-Reino11, F. Díaz-González12, M. Tomsic8, K. Pavelka9, F. O'Shea5, C. Sullivan5, M. van de Sande13, I. E. van der Horst-Bruinsma13, G. J. Macfarlane14, G. T. Jones14, B. Gudbjørnsson15, T. K. Kvien16 on behalf of EuroSpA Study Group | ||||
1DANBIO, Glostrup, Denmark, 2ARTIS, Stockholm, Sweden, 3SCQM, Geneva, Switzerland, 4ROB-FIN, Helsinki, Finland, 5ASRI, Dublin, Ireland, 6BIOBADASER, Barcelona, Spain, 7reuma.pt, Almada, Portugal, 8biorx.si, Ljubljana, Slovenia, 9ATTRA, Prague, Czech Republic, 10GISEA, Bari, Italy, 11BIOBADASER, Santiago, 12BIOBADASER, Santa Cruz de Tenerife, Spain, 13ARC, Amsterdam, Netherlands, 14BSRBR-AS, Aberdeen, United Kingdom, 15ICEBIO, Reykjavik, Iceland, 16NORDMARD, Oslo, Norway | ||||
EULAR, Madrid, 2017 |
||||
, Abstract | ||||
, Czech, Denmark, Finland, Ireland, Italy, Norway, Slovenia, Spain, Sweden, Switzerland | ||||
Abstract: http://ard.bmj.com/content/76/Suppl_2/656.3 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2017 | English | , Epidemiological study | |
Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings | ||||
Schneider M, Mosca M, Pego-Reigosa JM, Gunnarsson I, Maurel F, Garofano A, Perna A, Porcasi R, Devilliers H | ||||
Policlinic of Rheumatology, Hiller Research Unit, Heinrich-Heine University, Düsseldorf, Germany. Department of Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy. Department of Rheumatology, Complexo Hospitalario Universitario de Vigo, Ourense y Pontevedra, Spain. Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden. HEOR, Real-World Evidence Solutions (RWES) unit, IMS Health, Paris-La Défense, France. Global Specialty Pharma Franchise, GlaxoSmithKline; Services Unlimited, Brentford, UK. Immunology Medical Department, GlaxoSmithKline spa, Verona, Italy. Department of Internal Medicine and Systemic Diseases, University Hospital of Dijon, 5bis INSERM U866 5ter INSERM CIC-EC 1432, Dijon, France. | ||||
Rheumatology (Oxford). 2017 May 1;56(5):818-828 |
||||
, Article | ||||
, France, Germany, Italy, Spain, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28204765 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Rheumatology | 2017 | English | , Retrospective Field Study | |
Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany. | ||||
Lyu R1, Govoni M2, Ding Q1, Black CM3, Kachroo S4, Fan T1, Ogbonnaya A5, Donga P5, Hill J5, Makin C5. | ||||
1Merck Co., Inc, Whitehouse Station, NJ, USA. 2MSD Italy, Rome, Italy. 3Merck Co., Inc, 126 E. Lincoln Avenue, Mail code: RY32-211, Rahway, NJ, 07065, USA. 4Merck Co., Inc, 126 E. Lincoln Avenue, Mail code: RY32-211, Rahway, NJ, 07065, USA. sumesh.kachroo@merck.com. 5IMS Health, Alexandria, VA, USA. | ||||
Rheumatol Int. 2016 Jan;36(1):143-53. |
||||
, Article | ||||
, Germany | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26314368 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2016 | English | , Retrospective database analysis | |
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study | ||||
Gerega S1, Millson B1, Bessette L2, Marshall JK3, Lebovic G4,5, Sung M1, Oraichi D1, Gaetano T6, Gazel S6, Latour M6, Laliberté MC6 | ||||
1 IMS Brogan, Kirkland, Quebec, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 4 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 5 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 6 AbbVie Corporation, St. Laurent, Quebec, Canada | ||||
American College of Rheumatology 2016 Annual Meeting, November 11-16, Washington DC, USA |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/abbvie-acr-poster-2016.pdf | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance, Rheumatology | 2016 | English | , Database Study | |
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. | ||||
Morlock R1, Chevalier P2, Horne L3, Nuevo J4, Storgard C1, Aiyer L1, Hines DM5, Ansolabehere X6, Nyberg F7,8 | ||||
1 Ardea Biosciences, San Diego, CA, USA 2 IMS Health HEOR, Zaventem, Belgium 3 AstraZeneca, Wilmington, DE, USA 4 AstraZeneca, Madrid, Spain 5 IMS Health HEOR, Fairfax, VA, USA, 6 IMS Health HEOR, Paris, France, 7 AstraZeneca, Mölndal, Sweden 8 University of Gothenburg, Gothenburg, Sweden | ||||
Rheumatol Ther., 2016, 3(1): 53-75 |
||||
, Article | ||||
, France, Germany, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2016 | English | ||
Validity of ankylosing spondylitis diagnoses in The Health Improvement Network | ||||
Dubreuil M, Peloquin C, Zhang Y, Choi HK, Inman RD, Neogi T | ||||
Boston University School of Medicine, Section of Rheumatology; VA Boston Healthcare System; Massachusetts General Hospital, Section of Rheumatology; University of Toronto, Toronto Western Hospital | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Rheumatology | 2016 | English | , Retrospective database analysis | |
Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study | ||||
Lee T, Lu N, Felson DT, Choi HK, Dalal DS, Zhang Y, Dubreuil M | ||||
Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital; Section of Rheumatology, Boston University School of Medicine | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2016 | English | , Retrospective database analysis | |
Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study | ||||
Lu N, Dubreuil M, Zhang Y, Neogi T, Rai SK, Ascherio A, Hernán MA, Choi HK | ||||
Clinical Epidemiology Unit, Boston University School of Medicine; Arthritis Research Centre of Canada, University of British Columbia; Department of Epidemiology, Harvard School of Public Health; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Miscellaneous, Rheumatology | 2016 | English | , Retrospective database analysis | |
Improved survival in rheumatoid arthritis: a general population-based cohort study | ||||
Zhang Y, Lu N, Peloquin C, Dubreuil M, Neogi T, Aviña-Zubieta JA, Rai SK, Choi HK | ||||
Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; Arthritis Research Canada, University of British Columbia, Vancouver; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2016 | English | , Retrospective database analysis | |
Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis | ||||
Gossen N, Jacob L, Kostev K | ||||
Rheumatol Int. 2016 Aug;36(8):1113-8 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Rheumatology | 2016 | English | , Retrospective database analysis | |
Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany. | ||||
Lyu R, Govoni M, Ding Q, Black CM, Kachroo S, Fan T, Ogbonnaya A, Donga P, Hill J, Makin C. | ||||
Rheumatol Int. 2016 Jan;36(1):143-53. doi: 10.1007/s00296-015-3348-4. |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2016 | English | ||
Drug utilization in rheumatoid arthritis from a large japanese hospital administrative database | ||||
Crawford B, Kim J | ||||
IMS Health, Real-world Evidence Solutions, Tokyo, Japan | ||||
pharmacoepidemiology and drug safety 2015; 24: 142 |
||||
, Abstract | ||||
, Japan | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2015 | English | , Retrospective database analysis | |
Septic arthritis in gout patients: a population-based cohort study | ||||
Lim SY, Lu N & Choi HK | ||||
Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School | ||||
Rheumatology (Oxford) |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2015 | English | , Retrospective database analysis | |
Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy. | ||||
Doria A1, Iaccarino L1, La Montagna G2, Mathieu A3, Piga M3, Galeazzi M4, Iuliano A4, Maurel FB5, Garofano AM5, Perna AG6, Porcasi RE7. | ||||
1Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy. 2Rheumatology Unit, Second University of Napoli, Napoli, Italy. 3Division of Rheumatology, Department of Medical Sciences, University of Cagliari, Cagliari, Italy. 4Department of Rheumatology, Ospedale Santa Maria alle Scotte, University of Siena, Siena, Italy. 5HEOR, Real-World Evidence Solutions (RWES) unit, IMS Health, Paris-La Défense, France. 6Immuno-Inflammation & Infectious Diseases (II-ID) Global Franchise, GlaxoSmithKline, London, UK. 7Speciality Care Medical Department, GlaxoSmithKline, Verona, Italy | ||||
Clinical and experimental rheumatology (2015) |
||||
, Article | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2015 | English | , Cost analysis, Observational study, Real World Data | |
REDUCTION IN C-REACTIVE PROTEIN WITH BIOLOGIC DRUGS IN RHEUMATOID ARTHRITIS AND SPONDYLITIS PATIENTS IN GERMAN RHEUMATOLOGIST PRACTICES | ||||
Gossen N, Kostev K | ||||
IMS Health, Frankfurt am Main, Germany | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Rheumatology | 2015 | English | ||
Characteristics, Referral and Treatment Patterns of Patients Diagnosed with Psoriatic Arthritis ? A Retrospective Cohort Study Based in Sweden | ||||
J. Rockberg1, M. Mittal2, A. Joshi2, Y. Bao2, J. Anderson3, R. Linder1, J. Stålhammar4, U. Lindqvist5 | ||||
1Real World Evidence Solutions & HEOR, Pygargus AB/IMS Health, Stockholm, Sweden 2Health Economics and Outcomes Research (HEOR) 3Immunology Clinical Development, AbbVie Inc, Chicago, United States 4Department of Public health and Caring Sciences; Family Medicine and Preventive Medicine 5Department of Medical Sciences, Uppsala University, Uppsala, Sweden | ||||
Ann Rheum Dis |
||||
, Oral presentation | ||||
, Nordic, Sweden | ||||
Abstract: http://ard.bmj.com/content/74/Suppl_2/64.2 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2015 | English | , Real World Evidence | |
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. | ||||
Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14. | ||||
1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 2Department of Rheumatology, CHU Strasbourg, Strasbourg, France. 3University of Cologne, Cologne, Germany. 4L Sacco University Hospital, Milan, Italy. 5University of Montreal, Montreal, Canada. 6Facultad de Medicina, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain. 7Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. 8Department of Rheumatology, University of Liverpool, Liverpool, UK. 9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. 10Hellenic Foundation for Rheumatological Research, Athens, Greece. 11Quintiles, Rockville, Maryland, USA. 12F Hoffmann-La Roche Ltd, Basel, Switzerland. 13Genentech Inc, San Francisco, California, USA. 14University Hospital of Geneva, Geneva, Switzerland. | ||||
Ann Rheum Dis. 2015 Jun;74(6):979-84 |
||||
, Article | ||||
, Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431330/ | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Rheumatology | 2015 | English | , Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles | |
Identifying psoriasis and psoriatic arthritis patients in retrospective databases when diagnosis code is not available: A validation study comparing medication/prescriber visit based algorithms to diagnosis codes | ||||
Dobson-Belaire W1, Borrelli R1, Goodfield J1, Liu FF2, Khan ZM3 | ||||
1IMS Brogan, Mississauga, ON, Canada, 2Celgene Inc., Mississauga, ON, Canada, 3Celgene Corporation, Summit, NJ, USA | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Rheumatology | 2014 | English | , Retrospective database analysis | |
Concomitant use of non-steroidal anti-inflammatory drugs (NSAIDS) and proton pump inhibitors (PPIS) in newly diagnosed patients with osteoarthritis (OA), rheumatoid arthritis (RA) or ankylosing spondylitis (AS) | ||||
Dziarmaga A1, Reidel K2, White R1, Tarride J1, Corner N2 | ||||
1AstraZeneca Canada Inc., Mississauga, ON, Canada, 2IMS Brogan Canada, Kirkland, QC, Canada | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2014 | English | , Database Study | |
Cost of a pulmonary arterial hypertension-related hospitalization in Belgium | ||||
Chevalier P1, De Beule J2, Lamotte M1, Hunsche E2, Regulier E2 | ||||
1IMS Health, Vilvoorde,Belgium, 2Actelion Pharmaceuticals Ltd., Allschwil, Switzerland | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2014 | English | , Cost analysis | |
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. | ||||
Ogdie A, Yu Y, Haynes K, Love TJ, Maliha S, Jiang Y, Troxel AB, Hennessy S, Kimmel SE, Margolis DJ, Choi H, Mehta NN & Gelfand JM | ||||
University of Pennsylvania Division of Rheumatology | ||||
Ann Rheum Dis. 2015 Feb;74(2):326-32. doi: 10.1136/annrheumdis-2014-205675. Epub 2014 Oct 28 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25351522 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Rheumatology | 2014 | English | , Retrospective database analysis | |
Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network. | ||||
Ogdie A, Alehashemi S, Love TJ, Jiang Y, Haynes K, Hennessy S, Choi H & Gelfand JM | ||||
University of Pennsylvania Perelman School of Medicine | ||||
Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):918-22. doi: 10.1002/pds.3677. Epub 2014 Jul 5. |
||||
, Article, Poster | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25044030 | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics, Rheumatology | 2014 | English | , Retrospective database analysis | |
Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study. | ||||
Rho YH, Lu N, Peloquin CE, Man A, Zhu Y, Zhang Y & Choi HK | ||||
Boston University School of Medicine The Clinical Epidemiology Unit | ||||
2016;75:91-95 Ann Rheum Dis doi:10.1136/annrheumdis-2014-205827 |
||||
, Article | ||||
, UK | ||||
Abstract: http://ard.bmj.com/content/early/2014/09/02/annrheumdis-2014-205827.abstract | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Rheumatology | 2014 | English | , Retrospective database analysis | |
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study | ||||
Dubreuil M, Rho YH, Man A, Zhu Y, Zhang Y, Love TJ, Ogdie A, Gelfand JM & Choi HK | ||||
Boston University School of Medicine Section of Rheumatology and the Clinical Epidemiology Unit | ||||
Rheumatology (Oxford). 2014 Feb;53(2):346-52. doi: 10.1093/rheumatology/ket343. Epub 2013 Oct 31. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894671/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Rheumatology | 2014 | English | , Retrospective database analysis | |
Comorbidities in rotator cuff disease: a case-control study | ||||
Titchener AG, White JJ, Hinchliffe SR, Tambe AA, Hubbard RB & Clark D | ||||
Royal Derby Hospital Department of Trauma and Orthopaedics | ||||
J Shoulder Elbow Surg. 2014 Sep;23(9):1282-8. doi: 10.1016/j.jse.2013.12.019. Epub 2014 Mar 4 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24618192 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Rheumatology | 2014 | English | , Retrospective database analysis | |
Annual Cost of Patients with Osteoarthritis of the Hip and Knee in France | ||||
Bertin P1, Rannou F2, Grange L3, Dachicourt JN4, Bruel P5, Emery C6, Grandfils N7, Taieb C8 | ||||
1Service de Rhumatologie, C.H.U. Dupuytren, Limoges, France, 2Service de Rééducation, Pôle Ostéo-Articulaire, C.H.U Cochin, Paris, France, 3Clinique universitaire de Rhumatologie, Pôle Locomotion Rééducation et Physiologie CHU de Grenoble/ Hôpital Sud, Echirolles, France, 4Association Française de Lutte Anti-Rhumatismale, Paris, France, 5Département Médical, Pierre Fabre Santé, Castres, France, 6CEMKA-EVAL, Pôle Biostatistiques, Bourg-La-Reine, France, 7IMS Health,Puteaux, France, and 8Public Health, PFSA, Paris, France | ||||
Journal of Musculoskeletal pain, Early Online : 1-9, 2014 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2014 | English | ||
Coût du Lupus Systémique (LS) en France des patients adultes avec une maladie active et traitée (étude LUCIE) | ||||
Amoura Z1, Deligny C2, Pennaforte JL3, Hamidou M4, Blanco P5, Hachulla E6, Pourrat J7, Queyrel V8, Garofano A9, Maurel F9, Levy-Bachelot L10, Boucot I10. | ||||
1Service de médecine interne 2, Centre national de référence lupus, hôpital La Pitié-Salpétrière, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. 2Service de médecine interne et rhumatologie, CHU de Fort-de-France, BP 63297261, Fort-de-France cedex, Martinique. 3Service de médecine interne, hôpital Robert-Debré, rue du Général-Koenig, 51090 Reims, France. 4Service de médecine interne, hôpital Hôtel-Dieu, place Alexis-Ricordeau, 44093 Nantes cedex 1, France. 5Service de médecine interne, hôpital Pèllegrin, place Amélie-Rabat-léon, 33076 Bordeaux cedex, France. 6Service de médecine interne, hôpital Huriez, 1, place de Verdun, 59037 Lille cedex, France. 7Service de néphrologie et immunologie clinique, hôpital Rangueil, 1, avenue du Professeur-Jean-Pouhlès TSA 50032, 31059 Toulouse cedex 9, France. 8Service de médecine interne, hôpital l'Archet, 151, route Saint-Antoine-Ginestière BP 79, 06202 Nice cedex 3, France. 9IMS Real-World Evidence Solutions, Health Economics & Outcomes Research, Tour Ariane, 5-7, place de la Pyramide, 92088 La Défense cedex, France. 10GlaxoSmithKline, 100, route de Versailles, 78163 Marly-le-Roi cedex, France. | ||||
Rev Med Interne. 2014 Nov;35(11):700-8 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Nephrology, Rheumatology | 2014 | French | , Cost of illness, Observational study, Retrospective Field Study | |
Annual direct medical cost of active systemic lupus erythematosus in five European countries. | ||||
Doria A1, Amoura Z, Cervera R, Khamastha MA, Schneider M, Richter J, Guillemin F, Kobelt G, Maurel F, Garofano A, Perna A, Murray M, Schmitt C, Boucot I. | ||||
1Division of Rheumatology, University of Padova, , Padova, Italy. | ||||
Ann Rheum Dis. 2014 Jan;73(1):154-60 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Nephrology, Rheumatology | 2014 | English | , Observational study | |
Annual Cost of Patients with Osteoarthritis of the Hip and Knee in France | ||||
Bertin P1, Rannou F2, Grange L3, Dachicourt JN4, Bruel P5, Emery C6, Grandfils N7, Taieb C8 | ||||
1Service de Rhumatologie, C.H.U. Dupuytren, Limoges, France, 2Service de Rééducation, Pôle Ostéo-Articulaire, C.H.U Cochin, Paris, France, 3Clinique universitaire de Rhumatologie, Pôle Locomotion Rééducation et Physiologie CHU de Grenoble/ Hôpital Sud, Echirolles, France, 4Association Française de Lutte Anti-Rhumatismale, Paris, France, 5Département Médical, Pierre Fabre Santé, Castres, France, 6CEMKA-EVAL, Pôle Biostatistiques, Bourg-La-Reine, France, 7IMS Health,Puteaux, France, and 8Public Health, PFSA, Paris, France | ||||
Journal Of Musculoskeletal Pain, Early Online: 1–9, 2014 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2014 | English | , Retrospective database analysis | |
Understanding Treatment Patterns of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Proton Pump Inhibitors (PPIs) in Patients with the Signs and Symptoms of Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS) | ||||
Dziarmaga A1, Reide Kl2, White R1, Tarride J1, Corner N2 | ||||
1 A straZeneca 2 IMS Brogan Canada (A Unit of IMS Health) | ||||
ISPOR 2014 |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/nsaids-ispor-banner-2014-print.pdf | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2014 | English | , Longitudinal study | |
Estimating the annual medical costs for newly treated dupuytren’s contracture patients in the real world. | ||||
Kowal S, Ferrufino C, Munakata J, Tursi J | ||||
Academy of Managed Care Pharmacy (AMCP) 26th annual Meeting & Expo, 2014 April, Tampa, FL |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2014 | English | , Cost analysis | |
Cost per treated patient for biologics for rheumatoid arthritis (RA) using US claims data. | ||||
Schabert VF1, Korn JR1, Bilir SP1, DeKoven M1, Harrison DJ2, Joseph G2 | ||||
1 IMS Health, Alexandria, USA, 2 Amgen Inc, Thousand Oaks, USA | ||||
European League Against Rheumatism 2013 Congress, Madrid, Spain |
||||
, Poster | ||||
, Spain, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost analysis | |
Algorithm-based estimation of biologic effectiveness for rheumatoid arthritis | ||||
Yun H1, Schabert VF2, Yeaw J2, Korn JR3, Quach C4, Harrison DJ5, Joseph G5, Collier D5 | ||||
1 University of Alabama at Birmingham, Birmingham, USA 2 IMS Health, Alexandria, USA 3 IMS Health, Waltham, USA 4 University of North Carolina at Chapel Hill, Chapel Hill, USA 5 Amgen Inc, Thousand Oaks, USA | ||||
International Society for Pharmacoeconomics and Outcomes Research 18th International Meeting, New Orleans, LA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost effectiveness | |
Effectiveness of second line biologic use in rheumatoid arthritis after switching from first-line biologics | ||||
Schabert VF1, Yeaw J1, Korn J2, Quach C3, Harrison DJ4, Yun H5, Joseph G4, Collier D4, Curtis J5 | ||||
1 IMS Health, Alexandria, VA, USA, 2 IMS Health, Waltham, MA, USA, 3 University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 4 Amgen Inc, Thousand Oaks, CA, USA, 5 University of Alabama, at Birmingham, Birmingham, AL, USA | ||||
International Society for Pharmacoeconomics and Outcomes Research 18th International Meeting, New Orleans, LA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Review | |
Cost per treated patient for biologics across adult indications using claims data | ||||
Schabert VF1, Yeaw J1, Korn J2, Quach C3, Harrison DJ4, Yun H5, Joseph G4, Collier D4, Curtis J5 | ||||
1 IMS Health, Alexandria, VA, USA, 2 IMS Health, Waltham, MA, USA, 3 University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 4 Amgen Inc, Thousand Oaks, CA, USA, 5 University of Alabama, at Birmingham, Birmingham, AL, USA | ||||
International Society for Pharmacoeconomics and Outcomes Research 18th International Meeting, New Orleans, LA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost analysis | |
Using a validated, claims data based algorithm to evaluate the effectiveness of self-injected vs. infused biologics for rheumatoid arthritis claims data | ||||
Schabert VF1, Yeaw J1, Korn J2, Quach C3, Harrison DJ4, Yun H5, Joseph G4, Collier D4, Curtis J5 | ||||
Academy of Managed Care Pharmacy 25th Annual Meeting, San Diego, CA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Observational study | |
Costs of tumor necrosis factor blockers per treated patient with psoriatic disease using real-world drug utilization data in a U.S. managed care population | ||||
Schabert VF, Watson C, Burudpakdee C, Joseph G, Iverson P, Harrison DJ | ||||
71st American Academy of Dermatology Annual Meeting, Miami Beach, FL |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost analysis | |
Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims. | ||||
Curtis JR1, Schabert VF2, Harrison DJ3, Yeaw J2, Korn JR2, Quach C4, Yun H5, Joseph GJ3, Collier DH6. | ||||
1Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama; Department of Epidemiology, University of Alabama, Birmingham, Alabama. Electronic address: jcurtis@uab.edu. 2IMS Health, Alexandria, Virginia. 3Global Health Economics, Amgen Inc, Thousand Oaks, California. 4Health Policy and Management, University of North Carolina, Chapel Hill, North Carolina. 5Department of Epidemiology, University of Alabama, Birmingham, Alabama. 6Inflammation/Development, Amgen Inc, Thousand Oaks, California. | ||||
Clin Ther. 2014 Jul 1;36(7):996-1004. |
||||
, Spain, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Cost effectiveness | |
A review of cost-effectiveness evaluations as part of national health technology assessments of biologic DMARDs in the treatment of rheumatoid arthritis. | ||||
Sergio Iannazzo 4, Maria De Francesco 1, David Gomez-Ulloa 2 & Maurizio Benucci 3 | ||||
1 IMS RWE Solutions & HEOR, Milan, Italy 2 IMS RWE Solutions & HEOR, Barcelona, Spain 3 Rheumatology Unit, Hospital S Giovanni di Dio, Florence Italy 4 IMS RWE Solutions & HEOR, Milan, Italy. | ||||
Expert Rev Pharmacoecon Outcomes Res., 2013, Aug, 13(4): 455-468 |
||||
, Article | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Review | |
Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. | ||||
Trifirò G1, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, Bianchini E, Medea G, Cricelli C, Caputi AP, Mazzaglia G | ||||
1Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Via Consolare Valeria Gazzi, 98125 Messina, Italy. | ||||
Ann Rheum Dis. 2013 May;72(5):694-700. doi: 10.1136/annrheumdis-2011-201254. Epub 2012 Jun 26. |
||||
, Article | ||||
, Italy | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22736095 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Epidemiological study, Retrospective database analysis | |
Prevalence and treatment patterns of psoriatic arthritis in the UK. | ||||
Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N, Mehta NN, Troxel A, Choi H & Gelfand JM | ||||
University of Pennsylvania Division of Rheumatology | ||||
Rheumatology (Oxford). 2013 Mar;52(3):568-75. doi: 10.1093/rheumatology/kes324. Epub 2012 Dec 7. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23221331 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Orthopedics, Rheumatology | 2013 | English | , Retrospective database analysis | |
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. | ||||
Choi H K, Rho Y H, Zhu Y, Soriano L C, Avina-Zubieta A & Zhang Y. | ||||
Ann Rheum Dis. 2013 Jul;72(7):1182-7. doi: 10.1136/annrheumdis-2012-201669. Epub 2012 Aug 28. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22930596 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease, Rheumatology, Vascular disease | 2013 | English | ||
The Use of Biologic Drugs for the Treatment of Rheumatoid Arthritis in Italy. | ||||
Heiman F, Katz P, Pegoraro V, Di Virgilio R | ||||
Cegedim Italy | ||||
16th Annual European ISPOR Congress Dublin, Ireland |
||||
, Poster | ||||
, Italy | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03365-2/abstract | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2013 | English | , Retrospective database analysis | |
Impact de la baisse du taux de remboursement des anti-arthrosiques symptomatiques d’action lente (AASALs) sur la prescription des AINS par les médecins généralistes français | ||||
P Hilliquin (1); S Bouée (2); I Dardour (3); A Letierce (4); V Leblanc (3); - (1) Corbeil-Essonnes - France; (2) Bourg-la-Reine - France; (3) Courbevoie - France; (4) Boulogne-Billancourt - France | ||||
26ème congrès français de Rhumatologie |
||||
, Poster | ||||
, France | ||||
Abstract: http://poster.rhumatologie.asso.fr/ | ||||
Condition | Year | Language | Analysis type | |
, Pain, Pricing and reimbursement, Rheumatology | 2013 | French | , Retrospective database analysis | |
Design of Lupus Impact Tracker (LIT) Validation Study in Five European Clinical Practice Settings | ||||
M. Schneider, M. Mosca, J.M. Pego-Reigosa, V. Koscielny, L. Moore-Ramdin, H. Devilliers | ||||
1Heine-University Heinrich Düsseldorf, Düsseldorf, Allemagne ; 2Université de Pise, Pise, Italie ; 3Hospital faire Meixoeiro, Vigo, en Espagne ; 4GlaxoSmithKline, Londres, Angleterre ; 5CHU de Dijon, Dijon, France. | ||||
ISPOR 16th 02/06 Novembre 2013 Dublin |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Nephrology, Rheumatology | 2013 | English | ||
Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study | ||||
Schabert VF, Bruce B, Ferrufino CF, Globe DR, Harrison DJ, Lingala B, Fries JF | ||||
1,3 IMS Health, Falls Church, VA. 2,6-7 Stanford University School of Medicine. 4-5 Amgen | ||||
Curr Med Res Opin |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2012 | English | , Observational study | |
Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States | ||||
Schabert VF, Watson C, Gandra SR, Goodman S, Fox KM, Harrison DJ | ||||
1,4 IMS Health, Falls Church, VA, US, 2-3,6 Amgen, 5 Strategic Healthcare Solutions | ||||
J Med Econ |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2012 | English | , Budget impact | |
Frequency of administration of biologics has an impact on treatment decision making. | ||||
Chevalier P1, Black C2,3, Lamotte M1, Crombach J4, Huismans J4, Rosiek R5, Fan T3 | ||||
1 IMS HEOR, Vilvoorde, Belgium 2 St. John’s University 3 Merck & Co. 4 MSD, Netherlands 5 Medithuis B.V. | ||||
15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany |
||||
, Abstract, Poster | ||||
, Netherlands | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2012 | English | , Retrospective database analysis | |
Obesity and the risk of psoriatic arthritis: a population-based study. | ||||
Love TJ, Zhu Y, Zhang Y, Wall-Burns L, Ogdie A, Gelfand JM, Choi HK. | ||||
Landspitali University Hospital Department of Science, Education, and Innovation | ||||
Ann Rheum Dis. 2012 Aug;71(8):1273-7. doi: 10.1136/annrheumdis-2012-201299. Epub 2012 May 14. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22586165 | ||||
Condition | Year | Language | Analysis type | |
, Obesity, Orthopedics, Rheumatology | 2012 | English | , Retrospective database analysis | |
Risk factors for pseudogout in the general population. | ||||
Rho YH, Zhu Y, Zhang Y, Reginato AM & Choi HK. | ||||
Boston University School of Medicine Section of Rheumatology and the Clinical Epidemiology Unit | ||||
Rheumatology (Oxford). 2012 Nov;51(11):2070-4. doi: 10.1093/rheumatology/kes204. Epub 2012 Aug 11. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22886340 | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics, Rheumatology | 2012 | English | , Retrospective database analysis | |
Therapy switching, augmentation, and discontinuation in patients with osteoarthritis and chronic low back pain. | ||||
Gore M, Sadosky AB, Leslie DL, Tai KS & Emery P. | ||||
Avalon Health Solutions, Inc. | ||||
Pain Pract. 2012 Jul;12(6):457-68. doi: 10.1111/j.1533-2500.2011.00524.x. Epub 2012 Jan 9. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22230466 | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics, Rheumatology | 2012 | English | , Retrospective database analysis | |
Estimating the Impact of Adherence to Allopurinol Therapy on Cardiovascular Outcomes in Gout Patients Using the Health Improvement Network (THIN) General Practice Database. | ||||
Rabi R, Elliott R & Quinn C | ||||
Society for Academic Primary Care (SAPC), SAPC Bristol 6-8 July 2011 |
||||
, Conference | ||||
, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(11)02385-0/abstract | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2012 | English | ||
Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. | ||||
Lapi F1, Simonetti M, Michieli R, Pasqua A, Brandi ML, Frediani B, Cricelli C, Mazzaglia G. | ||||
1Department of Preclinical and Clinical Pharmacology, University of Florence, Italy | ||||
Bone. 2012 Jan;50(1):85-90. doi: 10.1016/j.bone.2011.09.048. Epub 2011 Oct 2. |
||||
, Article | ||||
, Italy | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21985999 | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics, Rheumatology | 2012 | English | , Retrospective database analysis | |
Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study | ||||
Trifirò G1, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, Bianchini E, Medea G, Cricelli C, Caputi AP, Mazzaglia G | ||||
1Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Via Consolare Valeria Gazzi, 98125 Messina, Italy | ||||
Ann Rheum Dis. 2013 May;72(5):694-700 |
||||
, Abstract | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2012 | French | , Epidemiological study, Retrospective database analysis | |
Baseline characteristics and pre–index total health care and rheumatoid arthritis-related costs in patients receiving Golimumab therapy | ||||
Carter C1, Tandon N1, Smith D2 | ||||
1Centocor Ortho Biotech Services, LLC, Horsham, PA, USA, 2IMS Health Incorporated, Watertown, MA, USA | ||||
ISPOR 16th Annual International Meeting, May 21-25 2011, Baltimore, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/baltimore0511/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Cost of illness | |
Biologic experience and dosing of Golimumab patients in managed care | ||||
Carter C1, Tandon N1, Smith D2 | ||||
1Centocor Ortho Biotech Services, LLC, Horsham, PA, USA, 2IMS Health Incorporated, Watertown, MA, USA | ||||
ISPOR 16th Annual International Meeting, May 21-25 2011, Baltimore, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/baltimore0511/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Observational study | |
Explanatory factors for the Rheumatoid Arthritis patients' access to biological agents in 15 European countries | ||||
Laires PA1, Exposto F2, Barosa P2, Hormigos B2, Martins AP1 | ||||
1Merck, Sharp & Dohme, Oeiras, Portugal, 2IMS Health, Oeiras, Portugal | ||||
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
, Poster | ||||
Abstract: http://www.ispor.org/congresses/Spain1111/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Cost effectiveness | |
Costs of tumor necrosis factor blockers per treated patient across adult indications using real-world data in US commercially-insured population. | ||||
Schabert V1, Gandra SR2, Watson C2, Fox KM3, Yeaw J4, Goodman S4, Milev S5, Harrison DJ2. | ||||
1IMS Health, Falls Church, VA, USA, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4IMS Health, Watertown, MA, USA, 5IMS Brogan, A unit of IMS, Ottawa, ON, Canada | ||||
14th Annual European Congress, International Society of Pharmacoeconomics and Outcomes Research (ISPOR) |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.ispor.org/congresses/Spain1111/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Budget impact | |
Costs of tumor necrosis factor blockers per treated rheumatoid arthritis patient using real-world drug data in US commercially-insured population. | ||||
Schabert VF, Gandra S, Watson C, Yeaw J, Goodman S, Fox KM, Milev S, Harrison DJ. | ||||
ACR/ARHP Annual Scientific Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | ||
Etanercept treatment for psoriatic disease. | ||||
Schabert VF1, Harrison DJ2, Globe DR2, Goodman S1, Burudpakdee C1. | ||||
1 IMS Health, Falls Church, VA, US 2 2 Amgen, Thousand Oaks, CA, USA | ||||
Am J Pharm Benefits. 2011;3(3):e51-e58 |
||||
, Manuscript in preparation | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Budget impact | |
Patient characteristics, biologic experience, and real-world dosing of golimumab. | ||||
Carter CT1, Tandon N1, Smith DB2 | ||||
1Centocor Ortho Biotech Inc., Horsham, PA, USA, 2IMS Consulting Group, Watertown, MA, USA | ||||
The European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology, London, UK, May 25-28, 2011. |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Retrospective database analysis | |
Biologic experience and systemic medication use among commercially insured psoriasis patients receiving ustekinumab. | ||||
Carter CT1, Martin S1, Denny L1, Smith D2 | ||||
1Janssen Scientific Affairs, LLC., Horsham, PA, USA, 2IMS Consulting Group, Watertown, MA, USA | ||||
Society for Medical Decision Making (SMDM), October 23-26, 2011, Chicago, IL, USA |
||||
, Abstract, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | , Retrospective database analysis | |
Frequency and risk factors of gout flares in a large population-based cohort of incident gout. | ||||
Rothenbacher D, Primatesta P, Ferreira A, Cea-Soriano L, Rodríguez LA. | ||||
Rheumatology (Oxford). 2011 May;50(5):973-81. doi: 10.1093/rheumatology/keq363. Epub 2011 Jan 12. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21228059 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2011 | English | ||
Prevalence of long-term oral glucocorticoid prescriptions in UK over the past 20 years. | ||||
Fardet L, Petersen I, Nazareth I. | ||||
UCL MRC General Practice Research Framework | ||||
Rheumatology (Oxford). 2011 Nov;50(11):1982-90. doi: 10.1093/rheumatology/ker017. Epub 2011 Mar 10. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21393338 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Rheumatology | 2011 | English | , Epidemiological study, Retrospective database analysis | |
Management of osteoporosis and associated quality of life in post menopausal women. | ||||
Cortet B1, Blotman F, Debiais F, Huas D, Mercier F, Rousseaux C, Berger V, Gaudin AF, Cotté FE. | ||||
1Laboratoire GlaxoSmithKline, Marly-le-Roi, France. | ||||
BMC Musculoskelet Disord. 2011; 12: 7. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034724/ | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics, Rheumatology, Womens Health | 2011 | English | , Prospective study | |
Impact of diabetes against the future risk of developing gout | ||||
Rodríguez LA, Soriano LC & Choi HK | ||||
Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain | ||||
Ann Rheum Dis. 2010 Dec;69(12):2090-4. doi: 10.1136/ard.2010.130013. Epub 2010 Jun 22. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136217/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Rheumatology | 2010 | English | , Retrospective database analysis | |
The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK | ||||
Cooper C, Steinbuch M, Stevenson R, Miday R & Watts NB | ||||
Rheumatology, University of Southampton | ||||
Osteoporos Int. 2010 Apr;21(4):569-77. doi: 10.1007/s00198-009-1003-1. Epub 2009 Jun 23. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19547906 | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics, Rheumatology | 2010 | English | , Retrospective database analysis | |
Risk of upper gastrointestinal tract events in risedronate users switched to alendronate. | ||||
Ralston SH, Kou TD, Wick-Urban B, Steinbuch M & Masud T | ||||
Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh | ||||
Calcif Tissue Int. 2010 Oct;87(4):298-304. doi: 10.1007/s00223-010-9401-0. Epub 2010 Aug 29. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20803291 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders, Rheumatology | 2010 | English | , Retrospective database analysis | |
Frequency and Risk Factors of Gout Flares in a Large Population-Based Cohort of Incident Gout | ||||
Rothenbacher D, Primatesta P, Ferreira A, Soriano L & Garcia Rodriguez L | ||||
Global Clinical Epidemiology, Novartis Pharma AG, Basel, Switzerland | ||||
Pharmacoepidemiology and Drug Safety (19): S1-S347 |
||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2010 | English | , Retrospective database analysis | |
Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. | ||||
Breuil V1, Cortet B, Cotté FE, Arnould B, Dias-Barbosa C, Gaudin AF, Regnault A, Roborel de Climens A, Legrand E. | ||||
1Rheumatology Department, Nice University Hospital, Nice, France. | ||||
Osteoporos Int. 2012 Feb;23(2):445-55 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology, Womens Health | 2010 | English | , Prospective study, Quality of life, Retrospective database analysis | |
Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment. | ||||
Huas D1, Debiais F, Blotman F, Cortet B, Mercier F, Rousseaux C, Berger V, Gaudin AF, Cotté FE. | ||||
Department of General Practice, UFR Paris 7, Paris, France. | ||||
BMC Womens Health. 2010 Aug 20;10:26 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology, Womens Health | 2010 | English | , Prospective study | |
Differences in annual medication costs and dosage-increase rates between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population. | ||||
Ollendorf DA1, Klingman D2, Hazard E, Ray S3 | ||||
1 IMS Health, Inc., Norwalk, CT, USA 2 IMS Health, Inc., Falls Church, VA, USA 3 Abbott Laboratories, Abbott Park, IL, USA | ||||
Clinical Therapeutics, 2009, 31(4): 825-835 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | English | , Retrospective database analysis | |
Percepción de los médicos de Atención Primaria en el manejo clínico de la osteoporosis. Influencia de los Planes de Salud. [Primary care perception of clinical management of osteoporosis. The influence of healthcare policies] | ||||
Carbonell Abella C, Abizanda González M, Pérez Hernández M, Roset Gamisans M, Nogués Solán X | ||||
Carbonell Abella C1, Abizanda González M2, Pérez Hernández M3, Roset Gamisans M4, Nogués Solán X5 1 Centro de Salud Vía Roma. Barcelona. Facultad de Medicina. Universidad de Barcelona. España. 2 Centro de Atención Primaria Vila Olímpica. Barcelona. España. 3 Laboratorios Almirall. Barcelona. España. 4 IMS Health. Barcelona. España. 5 eUnidad de Investigación de Fisiopatología Ósea y Articular del Institut Municipal d'Investigacions Mèdiques (IMIM). Departamento de Medicina Interna. Universidad Autónoma de Barcelona. Hospital del Mar. Barcelona. | ||||
Semergen 2009;35(3)122-30 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.elsevier.es/revistas/ctl_servlet?_f=7012&articuloid=13135236&revistaid=40 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | Spanish | , Survey research | |
Indirect costs of rheumatoid arthritis and their determinants | ||||
Maurel F1, Bardoulat I1, Camara C2, Schadtler Law L3, Le Pen C4 | ||||
1 IMS Health, Puteaux, France, 2 Wyeth Pharmaceuticals France, Paris La Défense , France, 3 Wyeth Pharmaceuticals France, Paris La Défense Cedex, France, 4 Dauphine University, Paris, France | ||||
EULAR 2009 ISPOR 12th Annual European Congress, Paris, France 24-27 October 2009 |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/congresses/paris1009/Posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | English | , Economic evaluation | |
Impact of Rheumatoid Arthritis (RA) on working conditions and income | ||||
Maurel F1, Fautrel B2, Maravic M3, Bardoulat I1, Preiss P4, Camara C5, Schadtler Law L6, Le Pen C7 | ||||
1 IMS Health, Puteaux, France 2 Groupe Hospitalier Pitié-Salpêtrière, Paris, France, 3 Hopital Leopold Bellan, Paris, France, 4 Association Française des Polyarthritiques, Paris, France, 5 Wyeth Pharmaceuticals France, Paris La Défense, France, 6 Wyeth Pharmaceuticals France, Paris La Défense Cedex, France, 7 Dauphine University, Paris, France | ||||
ISPOR 12th Annual European Congress, Paris, France, 24-27th October 2009 |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/congresses/paris1009/Posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | English | , Burden of illness | |
Healthcare costs for rheumatoid arthritis patients treated with abatacept, infliximab, or rituximab. | ||||
Trivedi DN1, Chapman RH2, Smith D1, Semroc G2, Rosenblatt LC1 | ||||
1 Bristol-Myers Squibb, Plainsboro, NJ, USA 2 IMS Health, Inc., Falls Church, VA, USA | ||||
Academy of Managed Care Pharmacy's 21st Annual Meeting, 2009, April 15-18, Orlando, FL, USA |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | English | , Retrospective cohort analysis | |
Dosing patterns for rheumatoid arthritis patients treated with abatacept or infliximab. | ||||
Trivedi DN1, Chapman RH2, Smith D2, Semroc G2, Rosenblatt LC1 | ||||
1 Bristol-Myers Squibb, Princeton, NJ, USA 2 IMS Health, Inc., Falls Church, VA, USA | ||||
Value in Health, 2009, 12(3): A65 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | English | , Retrospective cohort analysis | |
Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population. | ||||
Ollendorf DA, Klingman D, Hazard E, Ray S. | ||||
IMS Health, Inc., Norwalk, Connecticut, USA. dollendorf@icer-review.org | ||||
Clin Ther. 2009 Apr;31(4):825-35. |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | English | , Retrospective database analysis | |
Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. | ||||
Joyce AT, Smith P, Khandker R, Melin JM, Singh A. | ||||
PharMetrics, Inc., 311 Arsenal Street, Watertown, MA 02472, USA. ajoyce@us.imshealth.com | ||||
J Rheumatol. 2009 Apr;36(4):743-52. Epub 2009 Feb 17. |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | English | , Retrospective database analysis | |
Healthcare costs for rheumatoid arthritis patients treated with abatacept, infliximab, or rituximab. | ||||
Chapman RH1, Smith D, Semroc G1, Trivedi DN, Rosenblatt LR. | ||||
2 IMS Health, Falls Church, VA, USA 4 IMS Health, Falls Church, VA, USA | ||||
2008 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, Academy of Managed Care Pharmacy’s 21st Annual Meeting, 2009, April 15-18, Orlando, FL, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2008 | English | , Retrospective cohort analysis | |
Expectativas, preferencias y satisfacción de los pacientes con artritis reumatoide en tratamiento con infliximab. [Expectations, preferences and satisfaction of patients with rheumatoid arthritis receiving infliximab treatment] | ||||
Carbonell J1, Badia X2, EXPRESAR GROUP | ||||
1Servicio de Reumatología. Hospital del Mar. Barcelona. 2Health Economics & Outcomes Research. IMS Health. Barcelona. España. | ||||
Med Clin (Barc) 2008;131(13):493-9. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19007577 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2008 | Spanish | , Quality of life | |
Using HAQ to estimate HUI3 and EQ-5D utility values in Spanish rheumatoid arthritis patients | ||||
Fernández I, Varela C, Layola M, Ruiz MD, Navarro F | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2008 | English | , Quality of life | |
European study of health related quality-of-life in patients with gout. | ||||
Van Vlaenderen I1, Strens D1, Annemans L, Murdock SC | ||||
1 IMS Health, Brussels, Belgium | ||||
Ann Rheum Dis., 2008, 67(Suppl II): 580 |
||||
, Article | ||||
, Europe | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2008 | English | , Quality of life | |
Patterns of rituximab use among patients in a managed care setting: results from a U.S. claims data analysis. | ||||
Pelletier EM1, Yu E2 | ||||
1IMS Health, Watertown, MA, USA, 2Genetech Inc., South San Francisco, CA, USA | ||||
Academy of Managed Care Pharmacy (AMCP) Educational Conference, 2008, October 15-18, Kansas City, MO, USA |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2008 | English | , Retrospective database analysis | |
The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study. | ||||
Poole CD, Conway P, Reynolds A & Currie CJ | ||||
360o Research Limited, Penarth | ||||
BMC Musculoskelet Disord. 2008 Nov 4;9:146. doi: 10.1186/1471-2474-9-146. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18983663 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2008 | English | , Retrospective database analysis | |
Hidden cost of rheumatoid arthritis: estimating cost of comorbid cardiovascular disease and depression among rheumatoid arthritis patients | ||||
Joyce AT, Khandker RK, Smith PJ, Singh A | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2007 | English | , Cost of illness | |
A microsimulation-based cost-utility analysis of Rituximab (Mabthera®) in patients with rheumatic arthritis in Spain | ||||
Fernández I, Varela C, Badia X, Carreño Á, Polanco C | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2007 | English | , Cost utility | |
Diagnostic indicators of restless legs syndrome in primary care consultations: the DESYR study. | ||||
Crochard A1, El Hasnaoui A, Pouchain D, Huas D, Arnulf I, Krieger J, Lainey E, Le Jeunne P, Leger D, Schuck S, Texier N, Tison F, Montplaisir J | ||||
1Laboratoire GlaxoSmithKline, Marly-le-Roi, France. | ||||
Mov Disord. 2007 Apr 30;22(6):791-7 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2007 | English | , Prospective study, Retrospective database analysis | |
Annual treatment costs of patients with rheumatoid arthritis with metotrexate and leflunomide in spain. | ||||
Rebollo P , Prieto L, Garcia A , Betegón L , Echevarria A | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Abstract | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2006 | English | , Cost of illness | |
Cost-utility analysis of rituximab as a new therapeutic option for rheumatoid arthritis patients in Canada | ||||
Mistry B1, McCormick J2, Diamantopoulos A3, Kielhorn A4 | ||||
1 Hoffmann-La Roche Ltd, Mississauga, ON, Canada, 2McKesson Phase 4 Solutions, Toronto, ON, Canada, 3M-TAG UK Ltd, London, UK, 4F. Hoffmann-La Roche Ltd, Basel, Switzerland | ||||
ISPOR 9th Annual European Congress. Copenhagen, Denmark Value in Health, 2006, 9(6): A222 |
||||
, Abstract, Poster | ||||
, Canada | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)63265-2/abstract | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2006 | English | , Cost utility | |
Prevalence of Depressive Symptoms in Postmenopausal Women with Low Bone Mineral Density and/or Prevalent Vertebral Fracture: Results from the Multiple Outcomes of Raloxifene Evaluation (MORE) Study. | ||||
Silverman SL, Shen W, Minshall ME, Xie S, and Moses KH. | ||||
The Journal of Rheumatology, 2007; 34(1):140-144. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2006 | English | , Epidemiological study | |
Development and validation of a satisfaction with treatment questionnaire in patients with rheumatoid artritis. | ||||
Carbonell J, Badia X and Grupo Expressar. | ||||
Reumatol Clin 2006;2(3):137-45 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2006 | English | , Quality of life | |
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. | ||||
Suissa S, Hudson M, Ernst P | ||||
Arthritis Rheum., 2006, 54(5): 1435-9 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2006 | English | , Retrospective database analysis | |
Do patients with older onset rheumatoid arthritis receive less aggressive treatment than younger patients | ||||
Tutuncu Z, Reed G, Kremer J, Kavanaugh A | ||||
Ann Rheum Dis 2006; 65(9):1226-1229 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2006 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
The CORRONA database | ||||
Kremer JM | ||||
Autoimmun Rev. 2006; 5(1):46-54 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2006 | English | , RWLPR (Real-World Late Phase Research-quintiles | |